Back to search
FDAFDA · Food and drugs·Recall number D-0432-2024

fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1

Published April 10, 2024 · Recall initiated: March 22, 2024

Summary

FDA records drug Class II recall D-0432-2024, published April 10, 2024 and initiated March 22, 2024. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 187 cassettes; Lot: Lot#: 20231020FEN-1, Exp: 04/17/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: leaking bags

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
IntegraDose Compounding Services LLC
Distributor
Nationwide within the U.S
Lot
Lot#: 20231020FEN-1, Exp: 04/17/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1 recalled?

Yes. FDA published recall D-0432-2024 on April 10, 2024. Reported hazard: Lack of Assurance of Sterility: leaking bags

What should I do if I have this product?

Voluntary: Firm initiated · Letter